The FDA approved TMS NeuroStar device to treat Obsessive-Compulsion Disorder in May 2022.
Many patients with treatment resistant depression have coexisting symptoms of insomnia that may have preceeded their depression and could increase their risk of relapse. Those with insomnia also have a higher chance to develop depression in addition to suicidal ideation. In the paper by Suh et al. 2013, they reported in their 6 year follow-up study that those who demonstrated two or more episodes of insomnia in non-depressed patients saw an increase risk of both depression and suicidal ideation. However, there are reports that show the improvements in patients with primary insomnia when treated with Transcranial Magnetic Stimulation (TMS). Sanchez-Escandon et al. 2014 reported that their patients with idiopathic insomnia saw improvements in total sleep time, sleep efficiency, sleep onset latency, total wake time, and wake time after sleep onset.
TMS is approved for Depression, however it does have offlabel affects on anxiety, insomnia, and OCD. Give us a call today for more information and how to get started with the Treatments.
Read the whole article here: https://www.clinicaltmssociety.org/news/2019-11/tms-and-insomnia
References:
Suh S, Kim H, Yang H-C, Cho ER, Lee SK, Shin C. Longitudinal Course of Depression Scores with and without Insomnia in Non-Depressed Individuals: A 6-Year Follow-Up Longitudinal Study in a Korean Cohort. Sleep. 2013;36(3):369-376. doi:10.5665/sleep.2452
Snchez-Escandón O, Arana-Lechuga Y, Terán-Pérez G, et al. Transcraneal Magnetic Stimulation Improves Sleep Parameters in Patients Affected with Imsomnia Associated to Electroencephalographic Abnormalities. Neurosci Med. 2014;05(01):72-77. doi:10.4236/nm.2014.51010
You Might Also Enjoy...
The FDA approved TMS NeuroStar device to treat Obsessive-Compulsion Disorder in May 2022.
Read about how we use magnetic resonance therapy (MeRT) as a customized use of Transcranial Magnetic Stimulation (TMS).
While TMS is an FDA approved treatment to relieve symptoms of treatment resistant depression, it can be used for many off-label purposes as well.
Historic events have unfolded in the past few year and studies have shown that there is a link between the current state of the news and individual's mental health.
The World Health Organization (WHO) released a scientific brief that stated that there was a dramatic 25% increase in the global prevalence of depression and anxiety during the first year of the COVID-19 pandemic.
Happy Brain Awareness Week! Read more about the effect of different brain chemical messengers and their effect on mental health and every day functioning.